Peak flow variability in childhood and body mass index in adult life

Enrico Lombardi; Debra A. Stern; Duane Sherrill; Wayne J. Morgan; Anne L. Wright; Judith Garcia-Aymerich; Ignasi Serra Pons; Stefano Guerra; Fernando D. Martinez

doi:10.1016/j.jaci.2018.10.035

Peak flow variability in childhood and body mass index in adult life

Enrico Lombardi
, Debra A. Stern
, Duane Sherrill
, Wayne J. Morgan
, Anne L. Wright
, Judith Garcia-Aymerich
, Ignasi Serra Pons
, Stefano Guerra
, Fernando D. Martinez

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1224-1226.e9
Journal	Journal of Allergy and Clinical Immunology
Volume	143
Issue number	3
DOIs	https://doi.org/10.1016/j.jaci.2018.10.035
State	Published - Mar 2019

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/j.jaci.2018.10.035

Cite this

@article{c9d37242c7c44a7da265eb1b97617aa2,

title = "Peak flow variability in childhood and body mass index in adult life",

author = "Enrico Lombardi and Stern, \{Debra A.\} and Duane Sherrill and Morgan, \{Wayne J.\} and Wright, \{Anne L.\} and Judith Garcia-Aymerich and \{Serra Pons\}, Ignasi and Stefano Guerra and Martinez, \{Fernando D.\}",

note = "Funding Information: Disclosure of potential conflict of interest: S. Guerra, A. L. Wright, D. A. Stern, W. J. Morgan, and F. D. Martinez received support for this research from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) (grant no. 132523). E. Lombardi has received fees or travel grants during the past 5 years from Angelini, Boehringer, Chiesi, Lusofarmaco, Omron, Vertex Pharmaceuticals, and Vifor. S. Guerra reports grants from NIH/NHLBI, NIH/National Institute of Allergy and Infectious Diseases (NIAID), and the Cystic Fibrosis Foundation. W. J. Morgan reports grants from NIH/NHLBI, NIH/NIAID, and the Cystic Fibrosis Foundation; personal fees from the Cystic Fibrosis Foundation; and personal fees from Genentech. F. D. Martinez reports grants from NIH/NHLBI, NIH/NIAID, NIH/National Institute of Environmental Health Sciences, NIH/Office of the Director, and Johnson \& Johnson. He was also a consultant for Commense INC and Copeval. The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: Disclosure of potential conflict of interest: S. Guerra, A. L. Wright, D. A. Stern, W. J. Morgan, and F. D. Martinez received support for this research from the National Institutes of Health (NIH)/ National Heart, Lung, and Blood Institute (NHLBI) (grant no. 132523 ). E. Lombardi has received fees or travel grants during the past 5 years from Angelini, Boehringer, Chiesi, Lusofarmaco, Omron, Vertex Pharmaceuticals, and Vifor. S. Guerra reports grants from NIH/ NHLBI , NIH/ National Institute of Allergy and Infectious Diseases (NIAID), and the Cystic Fibrosis Foundation . W. J. Morgan reports grants from NIH/ NHLBI , NIH/ NIAID , and the Cystic Fibrosis Foundation; personal fees from the Cystic Fibrosis Foundation; and personal fees from Genentech. F. D. Martinez reports grants from NIH/ NHLBI , NIH/ NIAID , NIH/ National Institute of Environmental Health Sciences , NIH/ Office of the Director , and Johnson \& Johnson . He was also a consultant for Commense INC and Copeval. The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: This study was supported by the National Heart, Lung, and Blood Institute (grant no. 132523 ). Funding Information: This study was supported by the National Heart, Lung, and Blood Institute (grant no. 132523).Disclosure of potential conflict of interest: S. Guerra, A. L. Wright, D. A. Stern, W. J. Morgan, and F. D. Martinez received support for this research from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) (grant no. 132523). E. Lombardi has received fees or travel grants during the past 5 years from Angelini, Boehringer, Chiesi, Lusofarmaco, Omron, Vertex Pharmaceuticals, and Vifor. S. Guerra reports grants from NIH/NHLBI, NIH/National Institute of Allergy and Infectious Diseases (NIAID), and the Cystic Fibrosis Foundation. W. J. Morgan reports grants from NIH/NHLBI, NIH/NIAID, and the Cystic Fibrosis Foundation; personal fees from the Cystic Fibrosis Foundation; and personal fees from Genentech. F. D. Martinez reports grants from NIH/NHLBI, NIH/NIAID, NIH/National Institute of Environmental Health Sciences, NIH/Office of the Director, and Johnson \& Johnson. He was also a consultant for Commense INC and Copeval. The rest of the authors declare that they have no relevant conflicts of interest.",

year = "2019",

month = mar,

doi = "10.1016/j.jaci.2018.10.035",

language = "English (US)",

volume = "143",

pages = "1224--1226.e9",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Peak flow variability in childhood and body mass index in adult life

AU - Lombardi, Enrico

AU - Stern, Debra A.

AU - Sherrill, Duane

AU - Morgan, Wayne J.

AU - Wright, Anne L.

AU - Garcia-Aymerich, Judith

AU - Serra Pons, Ignasi

AU - Guerra, Stefano

AU - Martinez, Fernando D.

N1 - Funding Information: Disclosure of potential conflict of interest: S. Guerra, A. L. Wright, D. A. Stern, W. J. Morgan, and F. D. Martinez received support for this research from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) (grant no. 132523). E. Lombardi has received fees or travel grants during the past 5 years from Angelini, Boehringer, Chiesi, Lusofarmaco, Omron, Vertex Pharmaceuticals, and Vifor. S. Guerra reports grants from NIH/NHLBI, NIH/National Institute of Allergy and Infectious Diseases (NIAID), and the Cystic Fibrosis Foundation. W. J. Morgan reports grants from NIH/NHLBI, NIH/NIAID, and the Cystic Fibrosis Foundation; personal fees from the Cystic Fibrosis Foundation; and personal fees from Genentech. F. D. Martinez reports grants from NIH/NHLBI, NIH/NIAID, NIH/National Institute of Environmental Health Sciences, NIH/Office of the Director, and Johnson & Johnson. He was also a consultant for Commense INC and Copeval. The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: Disclosure of potential conflict of interest: S. Guerra, A. L. Wright, D. A. Stern, W. J. Morgan, and F. D. Martinez received support for this research from the National Institutes of Health (NIH)/ National Heart, Lung, and Blood Institute (NHLBI) (grant no. 132523 ). E. Lombardi has received fees or travel grants during the past 5 years from Angelini, Boehringer, Chiesi, Lusofarmaco, Omron, Vertex Pharmaceuticals, and Vifor. S. Guerra reports grants from NIH/ NHLBI , NIH/ National Institute of Allergy and Infectious Diseases (NIAID), and the Cystic Fibrosis Foundation . W. J. Morgan reports grants from NIH/ NHLBI , NIH/ NIAID , and the Cystic Fibrosis Foundation; personal fees from the Cystic Fibrosis Foundation; and personal fees from Genentech. F. D. Martinez reports grants from NIH/ NHLBI , NIH/ NIAID , NIH/ National Institute of Environmental Health Sciences , NIH/ Office of the Director , and Johnson & Johnson . He was also a consultant for Commense INC and Copeval. The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: This study was supported by the National Heart, Lung, and Blood Institute (grant no. 132523 ). Funding Information: This study was supported by the National Heart, Lung, and Blood Institute (grant no. 132523).Disclosure of potential conflict of interest: S. Guerra, A. L. Wright, D. A. Stern, W. J. Morgan, and F. D. Martinez received support for this research from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) (grant no. 132523). E. Lombardi has received fees or travel grants during the past 5 years from Angelini, Boehringer, Chiesi, Lusofarmaco, Omron, Vertex Pharmaceuticals, and Vifor. S. Guerra reports grants from NIH/NHLBI, NIH/National Institute of Allergy and Infectious Diseases (NIAID), and the Cystic Fibrosis Foundation. W. J. Morgan reports grants from NIH/NHLBI, NIH/NIAID, and the Cystic Fibrosis Foundation; personal fees from the Cystic Fibrosis Foundation; and personal fees from Genentech. F. D. Martinez reports grants from NIH/NHLBI, NIH/NIAID, NIH/National Institute of Environmental Health Sciences, NIH/Office of the Director, and Johnson & Johnson. He was also a consultant for Commense INC and Copeval. The rest of the authors declare that they have no relevant conflicts of interest.

PY - 2019/3

Y1 - 2019/3

UR - https://www.scopus.com/pages/publications/85057603306

UR - https://www.scopus.com/pages/publications/85057603306#tab=citedBy

U2 - 10.1016/j.jaci.2018.10.035

DO - 10.1016/j.jaci.2018.10.035

M3 - Article

C2 - 30414860

AN - SCOPUS:85057603306

SN - 0091-6749

VL - 143

SP - 1224-1226.e9

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 3

ER -

Peak flow variability in childhood and body mass index in adult life

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this